North Star Investment Management Corp. Abbott Laboratories Transaction History

North Star Investment Management Corp.

$1.42 Billion
Q4 2024

A detailed history of North Star Investment Management Corp. transactions in Abbott Laboratories stock. As of the latest transaction made, North Star Investment Management Corp. holds 65,383 shares of ABT stock, worth $8.97 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

65,383

Previous 66,275 1.35%

Holding current value

$8.97 Million

Previous $7.56 Million 2.13%

% of portfolio

0.52%

Previous 0.53%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$111.93 - $119.39 $99,841 - $106,495	-892 Reduced 1.35%	65,383 $7.4 Million
Q3 2024 Oct 30, 2024	SELL	$100.07 - $118.13 $9,206 - $10,867	-92 Reduced 0.14%	66,275 $7.56 Million
Q2 2024 Aug 05, 2024	SELL	$100.73 - $112.44 $272,575 - $304,262	-2,706 Reduced 3.92%	66,367 $6.9 Million
Q1 2024 Apr 30, 2024	BUY	$109.52 - $120.96 $298,989 - $330,220	2,730 Added 4.11%	69,073 $7.85 Million
Q4 2023 Jan 10, 2024	SELL	$90.19 - $110.4 $8,477 - $10,377	-94 Reduced 0.14%	66,343 $7.3 Million
Q3 2023 Nov 06, 2023	BUY	$95.53 - $114.62 $6,113 - $7,335	64 Added 0.1%	66,437 $6.43 Million
Q2 2023 Aug 02, 2023	SELL	$100.78 - $112.29 $34,063 - $37,954	-338 Reduced 0.51%	66,373 $7.24 Million
Q1 2023 Apr 27, 2023	BUY	$96.86 - $114.01 $430,058 - $506,204	4,440 Added 7.13%	66,711 $6.76 Million
Q4 2022 Jan 11, 2023	SELL	$95.06 - $111.52 $136,316 - $159,919	-1,434 Reduced 2.25%	62,271 $0
Q3 2022 Nov 02, 2022	BUY	$96.76 - $112.03 $870 - $1,008	9 Added 0.01%	63,705 $6.16 Million
Q2 2022 Jul 19, 2022	SELL	$102.07 - $123.37 $19,597 - $23,687	-192 Reduced 0.3%	63,696 $6.92 Million
Q1 2022 May 03, 2022	SELL	$114.02 - $139.04 $248,107 - $302,551	-2,176 Reduced 3.29%	63,888 $7.56 Million
Q4 2021 Feb 07, 2022	SELL	$115.53 - $141.46 $203,448 - $249,111	-1,761 Reduced 2.6%	66,064 $9.3 Million
Q3 2021 Oct 20, 2021	BUY	$116.66 - $129.06 $933 - $1,032	8 Added 0.01%	67,825 $8.01 Million
Q2 2021 Jul 13, 2021	BUY	$105.79 - $124.53 $20,311 - $23,909	192 Added 0.28%	67,817 $7.86 Million
Q1 2021 Apr 19, 2021	BUY	$108.84 - $128.23 $38,855 - $45,778	357 Added 0.53%	67,625 $8.1 Million
Q4 2020 Jan 12, 2021	SELL	$105.0 - $114.42 $2,940 - $3,203	-28 Reduced 0.04%	67,268 $7.37 Million
Q3 2020 Oct 13, 2020	BUY	$91.64 - $111.29 $62,315 - $75,677	680 Added 1.02%	67,296 $7.32 Million
Q2 2020 Jul 16, 2020	SELL	$76.57 - $98.0 $894,337 - $1.14 Million	-11,680 Reduced 14.92%	66,616 $6.09 Million
Q1 2020 Apr 23, 2020	SELL	$62.82 - $91.86 $231,931 - $339,147	-3,692 Reduced 4.5%	78,296 $6.18 Million
Q4 2019 Jan 29, 2020	SELL	$78.51 - $87.4 $31,168 - $34,697	-397 Reduced 0.48%	81,988 $7.12 Million
Q3 2019 Oct 03, 2019	BUY	$81.84 - $88.74 $865,949 - $938,957	10,581 Added 14.74%	82,385 $6.89 Million
Q2 2019 Jul 15, 2019	BUY	$72.88 - $85.0 $1,603 - $1,870	22 Added 0.03%	71,804 $6.04 Million
Q1 2019 Apr 10, 2019	BUY	$66.22 - $80.06 $28,275 - $34,185	427 Added 0.6%	71,782 $5.74 Million
Q4 2018 Jan 07, 2019	BUY	$65.56 - $74.27 $25,896 - $29,336	395 Added 0.56%	71,355 $5.16 Million
Q3 2018 Oct 11, 2018	BUY	$60.81 - $73.36 $53,634 - $64,703	882 Added 1.26%	70,960 $5.21 Million
Q2 2018 Jul 20, 2018	BUY	$57.57 - $63.54 $5,123 - $5,655	89 Added 0.13%	70,078 $4.27 Million
Q1 2018 Apr 13, 2018	BUY	$56.27 - $63.62 $23,577 - $26,656	419 Added 0.6%	69,989 $4.19 Million
Q4 2017 Jan 11, 2018	BUY	$53.68 - $57.47 $1,073 - $1,149	20 Added 0.03%	69,570 $3.97 Million
Q3 2017 Oct 06, 2017	BUY	$48.06 - $53.64 $3.34 Million - $3.73 Million	69,550	69,550 $3.71 Million

Others Institutions Holding ABT

# of Institutions

3,372

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $240B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

News

Stay updated on North Star Investment Management Corp. with notifications on news.

Account

North Star Investment Management Corp. Abbott Laboratories Transaction History